Vaccine-Preventable Diseases

Publications

click to view chapters and sections

Disease Control Priorities in Developing Countries (2nd Edition)

1. 25. Acute Respiratory Infections in Children
   1. Causes of ARIs and the Burden of Disease
   2. Conclusions: Promises and Pitfalls
   3. Implementation of ARI Control Strategies: Lessons of Experience
   4. Interventions
   5. Research and Development Agenda
2. 56. Community Health and Nutrition Programs
   1. Community-Based Programs—What Are They?
3. 15. Cost–Effectiveness Analysis for Priority Setting
   1. Definition and Characteristics of Interventions
4. 19. Diarrheal Diseases
   1. Cost-Effectiveness of Interventions
   2. Preventive Strategies
   3. Research Agenda
5. 7. Economic Approaches to Valuing Global Health Research
6. 72. Ensuring Supplies of Appropriate Drugs and Vaccines
   1. Adherence
   2. Conclusion
   3. Dispensing
   4. Drug Policies
   5. Financing Issues
   6. Issues for the Future
   7. Local Production of Pharmaceuticals
   8. Prescription and Rational Use of Drugs
   9. Priorities for Pharmaceutical Research
   10. Procurement of Drugs
   11. Procurement of Vaccines
   12. Quality Assurance for Pharmaceuticals and Vaccines
   13. Selection of Drugs
   14. Selection of Vaccines
   15. Storage and Distribution of Essential Drugs and Vaccines
   16. Sustainable Financing of Vaccines and Immunizations
   17. The WHO Prequalification Schemes
   18. Vaccine Policies
   19. Vaccine Research Priorities
7. 12. Financing Health Systems in the 21st Century
8. 11. Fiscal Policies for Health Promotion and Disease Prevention
9. 29. Health Service Interventions for Cancer Control in Developing Countries
10. 8. Improving the Health of Populations: Lessons of Experience
    1. Cases
11. 54. Information to Improve Decision Making for Health
    1. Benefits, Costs, and Cost-Effectiveness of Improved Information
    2. Systems and Supply of Health Information
12. 2. Intervention Cost–Effectiveness: Overview of Main Messages
13. 1. Investing in Health
    1. Conclusions
    2. Development Assistance for Health
    3. Health System Development and Finance
14. 9. Millennium Development Goals for Health: What Will It Take to Accelerate Progress?
15. 27. Newborn Survival
16. 4. Priorities for Global Research and Development of Interventions
    1. Key Recommendations
17. 6. Product Development Priorities
    1. Financing and Institutional Arrangements for New Product Development
    2. Introduction
    3. Pharmaceutical Products
    4. Regulatory and Liability Issues
18. 53. Public Health Surveillance: A Tool for Targeting and Monitoring Intervention
19. 13. Recent Trends and Innovations in Development Assistance for Health
    1. Making Development Assistance for Health More Effective: Lessons Learned
    2. Recent Innovations to Improve the Effectiveness of Development Assistance for Health
    3. Trends and Gaps in Development Assistance for Health
20. 35. Respiratory Diseases of Adults
21. 5. Science and Technology for Disease Control: Past, Present, and Future
22. 17. Sexually Transmitted Infections
    1. Effectiveness of the Principal Interventions
23. 16. Tuberculosis
    1. Research and Development
    2. Summary of Cost-Effectiveness Analyses
24. 20. Vaccine–Preventable Diseases
    1. Acknowledgments
    2. Causes and Epidemiology of Diseases Prevented by Vaccines Used in National Immunization Programs
    3. Conclusions
    4. Cost-Effectiveness of Increasing Immunization Coverage for the Traditional EPI
    5. Costs and Cost-Effectiveness of Adding New Antigens to the Current Immunization Schedule
    6. Costs and Cost-Effectiveness of Existing Vaccination Programs
    7. Estimates of the Current Burden of Vaccine-Preventable Diseases and of the Burden Averted by Vaccination
    8. Expanded Program on Immunization
    9. Financial Sustainability of Immunization Programs
    10. Improving the Costs and Cost-Effectiveness of Immunization Programs
    11. Research Agenda

Global Burden of Disease and Risk Factors

1. 3. The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001

Priorities in Health

1. 1. Accomplishments, Challenges, and Priorities
2. 4. Cost–Effective Strategies for the Excess Burden of Disease in Developing Countries
   1. Infectious and Communicable Diseases
3. 3. Cost–Effectiveness Analysis
   1. What Are Appropriate Tasks for Cost-Effectiveness Analysis?
4. 7. Pillars of the Health System
   1. Information, Surveillance, and Research
5. 2. Success in Addressing Priorities
   1. Cost-Effective Interventions That Furthered Existing Health Systems

Chapter Presentations

Chapter 02. Intervention Cost-Effectiveness: Overview of Main Messages

1. Neglected Low-Cost Opportunities in Sub-Saharan Africa: Childhood Immunization, Malaria, and Childhood Illnesses
2. Neglected Low-Cost Opportunities in South Asia: Childhood Immunization, Lower Acute Respiratory Illness, and Maternal and Neonatal Care

Chapter 20. Vaccine-Preventable Diseases

1. Cost per Deaths and Disability Adjusted Life Years Averted by Vaccination, 2001
2. Deaths Averted by Vaccination for Hib and Hepatitis B, 2001
3. Deaths Averted by Vaccination for Measles and Yellow Fever, 2001
4. Annual Cost per Fully Immunized Child for the Traditional Childhood Vaccines, By Region, 2001
5. Annual Cost per Fully Immunized Child for the Traditional Childhood Vaccines, By Immunization Strategy, 2001
6. Disability Adjusted Life Years Lost from Vaccine-Preventable Diseases, 2001
7. Deaths Averted by Vaccination for Diphtheria and Whooping Cough, 2001
8. Deaths Averted by Vaccination for Tetanus and Polio, 2001

Chapter 60. Occupational Health

1. Impact of an Immunization Safety Program at Health Centers in Burkina Faso, 2000 and 2003